Showing results (31-40 of 2,634) with videos related to

Sort By:
Pageof 264
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cellsL Bergmann, P S Mitrou, M Demmer-Dieckmann, et al.
Annals of Hematology|March 1, 1995
Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemiaE Weidmann, J Brieger, B Jahn, et al.
Leukemia|December 1, 1994
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cellsJ Brieger, E Weidmann, K Fenchel, et al.
Onkologie|February 1, 1988
Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II studyP S Mitrou, C Fischer, D Huhn, et al.
Experimental Hematology|August 1, 1997
The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitroU Maurer, J Brieger, E Weidmann, et al.
Experimental Hematology|December 1, 1995
The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-beta 1L Bergmann, D K Schui, J Brieger, et al.
Diabetologia|January 22, 2005
Antioxidative treatment prevents activation of death-receptor- and mitochondrion-dependent apoptosis in the hearts of diabetic ratsJ Bojunga, D Nowak, P S Mitrou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II studyL Bergmann, T Karakas, G Lautenschlager, et al.
Onkologie|June 1, 1986
Age adapted induction and intensified consolidation therapy in acute myelogenous leukemiaE Kurrle, G Ehninger, M Freund, et al.
Scandinavian Journal of Haematology|September 1, 1982
Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markersL Bergmann, P S Mitrou, T Cherdron, et al.
Pageof 264